Cleared Special

K112007 - CARTO 3 EP NAVIGATION SYSTEM, VERSION 2.2 (FDA 510(k) Clearance)

Oct 2011
Decision
83d
Days
Class 2
Risk

K112007 is an FDA 510(k) clearance for the CARTO 3 EP NAVIGATION SYSTEM, VERSION 2.2. This device is classified as a Computer, Diagnostic, Programmable (Class II - Special Controls, product code DQK).

Submitted by Biosense Webster, Inc. (Diamond Bar, US). The FDA issued a Cleared decision on October 5, 2011, 83 days after receiving the submission on July 14, 2011.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1425.

Submission Details

510(k) Number K112007 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 14, 2011
Decision Date October 05, 2011
Days to Decision 83 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQK — Computer, Diagnostic, Programmable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1425

Similar Devices — DQK Computer, Diagnostic, Programmable

All 45
HemoSphere Nano Monitor (HSNANO1)
K253186 · Edwards Lifesciences, LLC · Feb 2026
CARTO™ 3 EP Navigation System V8.4
K252972 · Biosense Webster, Inc. · Feb 2026
Holter ECG and ABP system (HolterABP)
K251591 · Edan Instruments, Inc. · Feb 2026
CARTO™ 3 EP Navigation System V9.0 with PIU Plus
K254085 · Biosense Webster, Inc. · Jan 2026
LumiGuide Equipment R2.1
K252645 · Philips Medical Systems Nederland B.V. · Oct 2025
EnSite™ X EP System
K252013 · Abbott Medical · Sep 2025